Health
FDA Approves Groundbreaking HIV Prevention Drug After University of Utah Research
SALT LAKE CITY — In a major breakthrough for public health, the U.S. Food and Drug Administration (FDA) has officially approved lenacapavir (brand name: Yeztugo) — a long-acting HIV prevention drug built on pioneering research led by University of Utah biochemist Dr. Wesley Sundquist. The approval is being hailed as a
